Liberty One Investment Management »

Crispr Therapeutics shares owned by Liberty One Investment Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Liberty One Investment Management from 13F filings

Historical chart of Liberty One Investment Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Liberty One Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Liberty One Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $162k 2.4k 68.16
2023-12-31 $214k 3.4k 62.60
2023-09-30 $153k 3.4k 45.39
2023-06-30 $205k 3.6k 56.14
2023-03-31 $175k 3.9k 45.23
2022-12-31 $159k 3.9k 40.65
2022-09-30 $256k 3.9k 65.44
2022-06-30 $271k 1.7k 161.79
2022-03-31 $252k 4.0k 62.67
2021-12-31 $198k 2.6k 75.75
2021-09-30 $180k 1.6k 112.22
2021-06-30 $271k 1.7k 161.79
2021-03-31 $158k 1.3k 121.82
2020-12-31 $147k 958 153.44
2020-09-30 $81k 972 83.33
2020-06-30 $45k 614 73.29